Ex vivo liver resection combined with autotransplantation is a recently introduced approach to cure end-stage hepatic alveolar echinococcosis (HAE), which is considered unresectable by conventional radical resection due to echinococcal dissemination into the crucial intrahepatic conduits and adjacent structures. This article aims discuss the manipulation details and propose reasonable indications for this promising technique.
| INTRODUCTION
Hepatic alveolar echinococcosis (HAE) is a life-threatening parasitic disease caused by the larvae of Echinococcus multilocularis, leading to comprehensive invasion of multiple intrahepatic structures. 1 Japan, and Alaska. 3 China alone endures 90% of the global burden of AE, with over 16 000 primarily diagnosed cases every year. 4, 5 To date, radical hepatectomy accompanied by albendazole therapy is deemed to be the best solution for HAE. 6 Unfortunately, the insidious onset and slow progression of HAE usually result in delayed diagnosis. Thus most patients miss their chance for radical resection due to multiple lesions and severe intrahepatic structure invasion; only 35% of patients are eligible for radical hepatectomy. 7 Palliative surgery, such as lesion reduction surgery or cholangial drainage, does not notably benefit patient survival. Oral chemotherapy, such as albendazole, may postpone HAE progression, but the results are still far from satisfactory. [8] [9] [10] Liver transplantation (LT) has been applied as the last-resort therapy and as the only opportunity for radical cure of HAE since 1985. 7, 11 This application has been expanded through living donor liver transplantation (LDLT) 12, 13 ; however, the limitations are obvious: post-LT complications, recurrence associated with the management of immunosuppressive drugs, the shortage of organ donations, and the intolerably high expense of treatment have impaired the wide application of LT. 7, 14 In 1988, Pilchmayr et al 15 pioneered and presented the concept of extracorporeal liver surgery, which was applied for advanced malignant tumors. However, the outcome of this brilliant technique was not satisfactory due to the high incidence of unmanageable complications and postoperative recurrence. 16, 17 End-stage HAE is a relatively benign disease characterized by single or multiple large lesions that have extensively invaded crucial intrahepatic conduits or even hilum, thus making conventional hepatectomy impossible because the liver cannot tolerate the length of time required for the reconstruction procedure following resection. The above-mentioned limitations prompted us to apply ex vivo liver resection and autotransplantation (ERAT) for HAE. We conducted the first reported ERAT for advanced HAE with replacement of the retrohepatic inferior vena cava (IVC) using autologous vein grafting. 18 The result was satisfactory and encouraged us to explore more details of ERAT. In this report, we retrospectively studied 31 cases of ERAT performed at our center with the aim of discussing the feasibility, indications, preparation, technical details, and postoperative outcomes of this promising technique.
| MATERIALS AND METHODS

| Patient selection
From January 2014 to June 2017, 31 patients were selected to undergo ERAT. The study was approved by the ethics committee of West China 
| Pretransplant evaluation
All patients were evaluated by imaging tools, including MRI and computed tomography (CT) ( Figure 1A ), to assess the characteristics of the lesions, the portal hilum involvement, and the length and diameter of RHVC invasion, as well as to evaluate whether there was evidence of extrahepatic metastasis. A 3-dimensional (3D) imaging analysis system 19 calculated remnant liver volume (RLV) and visualized the vascular and biliary tract anatomy and the spatial location of the large masses ( Figure 1B ). The standard liver volume (SLV) was calculated following the experience of Urata et al 20, 21 For patients with highly suspected extrahepatic metastases, positron emission tomography-computed tomography (PET-CT) was essential to determine whether there were any potential surgical contraindications. Ultrasonography (US) evaluation of the large abdomen vessels was necessary to assess the vascular flow status and the presence or absence of "rich collateral circulation." 22 US of the bilateral great saphenous vein (GSV) was performed to evaluate its diameter and length for the reconstruction of the RHVC. If patients had persistent obstructive jaundice and biliary dilatation before the operation, X-ray-or US-guided percutaneous transhepatic cholangial drainage (PTCD) was performed to alleviate the bilirubin level and biliary obstruction. Patients with cholestatic jaundice were eligible for ERAT if the total bilirubin (TBIL) level was less than twice the upper limit of normal. After meticulous preoperative assessment and repetitive MDT discussions concerning the difficulties of conduit reconstruction and potential liver failure, the ERAT procedure would be conducted with the preparation of a blood type-matched donation after cardiac death (DCD) liver graft. In addition, the evaluation of the patient's family members as donors for LDLT would be initiated when DCD LT was not available, or if the waiting period was too long.
| Surgical procedures
| Exploratory surgery
The surgical procedure was based on LDLT, 23 The liver was moved into an ice bath for bench resection after the successful procurement of the entire liver.
| Anhepatic phase management
In the anhepatic phase, an artificial vascular graft (InterGard, InterVascular SAS, Inc., La Ciotat, France) was applied to temporarily reconstruct the IVC. A portocaval shunt was then established between the portal vein (PV) stump and the temporary IVC. Stable hemodynamics was maintained by these 2 routine procedures
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( Figure 1D ). Blood gas analysis (including pH, lactate [LAC] , and blood oxygen saturation) was performed at 1-hour intervals, and anesthetic adjustments were made accordingly.
| Ex vivo liver resection
The ex vivo liver resection was simultaneously performed by another group of surgeons. The liver was perfused with 4-8 L of 0-4°C HTK solution (histidine-tryptophan-ketoglutarate, HTK, Custodiol, Dr.
Franz Kohler Chemie, Germany) via the PV while cooled in an ice bath.
Parenchymal transection was performed with a minimum 1.0-cm lesionfree margin using the Cavi-Pulse Ultrasonic Surgical Aspirator (CUSA, Valleylab, Boulder, CO). The procedure for the parenchyma transaction was similar to that of liver graft harvesting from living donors, which was introduced in our previous studies. 24, 25 Notably, the left hepatic vein (HV), hepatic artery (HA), hepatic bile duct (HD), and the PV were carefully protected for subsequent reconstruction ( Figure 1E ). To ensure a radical removal of the lesion, frozen-section specimens of the transection margin were frequently sent for pathological examination, which revealed no evidence of HAE invasion. In addition,, the autograft was inspected by repeated perfusion to avoid any potential bile leakage or vascular rupture. The volume and weight of the autograft were recorded before it was stored in a 4°C refrigerator.
| IVC reconstruction
After the completion of bench resection, the temporary IVC and portocaval shunt were removed. IVC reconstruction is the final process prior to replacing the autograft in situ. The materials for reconstruction included artificial vessels, autologous vessels, and allogenic vessels. The autologous vessels (including the GSV, portions of the HAE-free hepatic vein, a posterior segment of the RHVC, and the inferior mesenteric vein) were selected primarily. 18, 26 Typically, the autologous veins were vertically split and annularly assembled as the graft of IVC 18 ( Figure 1F ). For patient 26, the new IVC was extended above the mediastinum because the HAE lesion had invaded the pericardium (Figure 2A, a) . It is notable that for patient 27 ( Figure 2B, b) and patient 31 ( Figure 2C, c) , the entire IVC was not reconstructed. In the other 5 cases, the temporary IVC, which was rebuilt using an artificial graft, was not removed because the bilateral GSV was too short to be the source of the IVC reconstruction.
| Bile duct and PV reconstruction
The maneuvers and materials for PV and HV revascularization ( Figure 3A , B, C) were similar to those used for the IVC (Figure 2 ).
After the outflow and PV were successfully reconstructed, the anhepatic period ended. Warming water was administered to the surface of the autograft to accelerate reperfusion. Subsequently, HA anastomosis and biliary duct reconstruction were performed. The number of segmental HDs in the autograft varied from 1 to 4 and necessitated diverse approaches for reconstruction, including left HD and common bile duct (CBD) anastomosis, Roux-en-Y hepaticojejunostomy, or a combination of these 2 approaches ( Figure 3D , E, F). A careful F I G U R E 2 Three complex inferior vena cava reconstruction methods and state of the liver autograft implanted. (A and a) For patient 26, the new IVC was extended above the mediastinum, which was rebuilt using bilateral GSVs. Left PV to portal trunk, end-to-end anastomosis; left HD to CBD, end-to-end anastomosis. The left hepatic artery was anastomosed to the end of the hepatic proper artery. (B and b) For patient 27, the IVC was partially rebuilt using an artificial vascular graft due to the rich collateral circulation. The GSV patches were adopted to rebuild the outflow. The hepatic hilum reconstructions were similar in patient 27 as in patient 26. (C and c) For patient 31, the IVC was not rebuilt due to the rich collateral circulation, and an HAE-free piece of IVC was used to repair the left hepatic vein. The hepatic artery and bile duct reconstructions were similar to those used for patient 26, but the portal vein was extended by 2 GSV loop patches to the portal trunk examination of the autograft for any possible bile leakage and bleeding was the final step.
| Postoperative management
The patients were admitted to a special ward for ERAT after surgery.
Liver and kidney function, autograft ultrasound, and complete blood count were examined regularly. for at least half a year. Drainage was extended in cases in which hemorrhage or bile leakage occurred. All patients were administered albendazole (15 mg/kg/day) routinely for 1 year after ERAT. 27 The patients returned for follow-up visits every 3-6 months after discharge.
| RESULTS
Thirty-one patients underwent ERAT successfully after MDT discussion, and there were no intraoperative deaths. The 31 patients (F) The hepatic ducts of the S3 segment were anastomosed to the CBD with a small anesthetic tube (white arrow), and hepaticojejunostomy was performed on the hepatic ducts of the S2 segment with a small anesthetic tube (white arrow) used in 1 patient. The remaining 23 patients (74.2%) underwent autologous revascularization of the IVC. Details of conduit reconstruction are presented in Figure 3 and Table 2 . The median operative time was 12.5 hours (range 9.4-19.5 hours), the median anhepatic time was 309 minutes (range 180-460 minutes). The median weight of the autograft was 636 g (range 360-1300 g). The rest of intraoperative parameters were reported in Table 2 .
Postoperative complications occurred in 13 patients, and complications classified as Clavien-Dindo grade 28 III or higher appeared in 5 patients (Table 3) 
| DISCUSSION
HAE is a rare and deadly parasitic disease in the northern hemisphere, especially in western China. 4, 5 In recent years, HAE cases have been expanding rapidly in Europe, Australia, and the United States from the countryside to urban areas, largely due to the increasing fox populations, the increasing encroachment of foxes into urban areas, and other factors such as spillover of Echinococcus multilocularis infection from wild carnivores to domestic dogs. 29 The World Health Organization has made great efforts to improve the management of HAE and the quality of life of patients with HAE, but many of these patients fail to receive timely treatment. 30 HAE is alluded to as "parasitic cancer,"
which exhibits tumor-like features with infiltrative growth. The Clavien-Dindo classification of surgical complications based on the report of Clavien PA, et al.
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resection is the first-line treatment for HAE patients. However, patients in the Chinese endemic areas frequently have lack of medical resources. More seriously, many patients lack the inclination to visit a hospital for therapy because HAE is considered a benign disease with no significant symptoms. Therefore, these patients lose the best chances for radical resection in the early stage HAE, and they must undergo treatment with oral albendazole tablets or palliative external drainage without an alternative treatment option. [8] [9] [10] Liver transplantation has provided a life-saving technique for patients with "unresectable" but not metastatic HAE lesions. 11, 13, 14, [31] [32] [33] [34] [35] Several centers had reported their work, which was summarized in Table 4 . According to the experience of a European collaborative report, severe infection and recurrence of HAE are primarily responsible for early postoperative mortality (9/45, 20%), 35 which is consistent with the outcomes from our center. 31, 34 Multiple elements, for instance, the shortage of graft donors and high incidence of postoperative recurrence associated with mandatory immunosuppressive therapy, eventually led to limited utilization of LT. These limitations prompted us to explore an alternative that could overcome these impediments. Thus ERAT was introduced. Since Wen et al 36 reported a case with such a technique in 2011, a few centers have also started using this approach. 18, 22, 36, 37 Two deaths were reported previously, 1 from PV thrombosis 37 and 1 from acute liver failure in POD12.
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Nonetheless, the details of indication, manipulation, and postoperative management remain controversial. According to our experience, this promising technique is feasible for end-stage HAE with a convincing outcome; in our hands, it had a mortality rate of only 6.5% and a 16.1% morbidity rate classified as Clavien-Dindo grade III or above, and no recurrence was detected up to the writing of this article. To the best of our knowledge, this case series constitutes the world's largest series of patients with end-stage HAE who underwent ERAT with multiple novel surgical technical details.
The meticulous selection of candidates is the basis for ensuring a smooth treatment outcome. HAE is preferably considered a benign disease; despite its tumor-like infiltrative growth, a relatively long time between primary infection and presentation of symptoms enables adequate compensatory function of the disease-free lobe of the liver.
We consider it as the result of the obstruction of the PV branch and the biliary tract caused by the lesion pressure, which increases the blood inflow of the disease-free lobes. In our study, the ratio of RLV to ing. 40, 41 In addition, the GSVs are easy to harvest, and their removal does not cause many adverse effects; all the preceding reasons make the GSV the ideal material for vascular reconstruction. 26, 32, 35 The management of the anhepatic phase is another key issue for maintaining an uneventful intraoperative course. Before the successful procurement of the entire liver, complete vena cava occlusion can lead to severe systematic circulation disorders and intestinal congestion. patient 31 experienced a transient lower extremity edema and recovered in POD7. None of the patients had renal function impairment.
The reconstruction of the inflow and outflow of the autologous graft requires attentive angioplasty because the intrahepatic conduits were frequently invaded by huge HAE lesions; moreover, the actual extent of the invasions was often found to be more serious than estimated by the preoperative assessment. The anastomosis of the PV circumstantially requires extension of the stump to prevent postoperative stenosis and kinking. The scheme for reintegrating the bile duct is difficult. Two or more orifices of bile duct are often found during the bench resection due to various mutations of the biliary system, which is difficult to identify from the orifice of other vessels because the graft is cooled in an ice bath and has no blood flow.
Two mortalities were reported. One patient died from postoperative intraabdominal bleeding originating from intercostal arteries.
In this case, a large proportion of the diaphragm was removed and repaired by an artificial patch due to unexpected extensive invasion, which might be primarily responsible for the observed postoperative bleeding and consequent death. The incident might have been prevented by a more detailed preoperative assessment and delicate operative technique. Another patient died of acute cerebral hemorrhage;
we speculate that this event was caused by excessive postoperative anticoagulant therapy. The most frequent cause of postoperative morbidity was bile leakage, with an incidence of 12.9% (4/31), which is lower than the incidence of 46.7% reported by Wen et al. 22 Stenosis was detected at the HV in 1 case after 2 months of follow-up, which may be a result of anastomosis scarring or hepatic vein kinking caused by pressure from the enlarged liver graft. Of interest, no hepatic insufficiency or failure was found in our case series; we attribute this to precise preoperative assessment of the graft volume and to the preoperative interventional modalities for mitigating obstructive jaundice.
Our experience from 31 cases indicated that ERAT is feasible for treating end-stage HAE. However, this study is inevitably associated with certain shortcomings, namely, a rather short follow-up period and the lack of a control group. Meanwhile, the advantage of autologous veins over artificial and allogeneic grafts as material for vessel reconstruction remains uncertain, and the intraoperative process of managing the oxygen metabolism, body fluid balance, and inflammatory responses needs to be fully studied. More rigorous experimental designs with large sample sizes are needed to assess the detailed utility of this technology.
ERAT provides a radical treatment option for advanced HAE that does not require an organ donor or immunosuppressive therapy.
Accurate preoperative evaluation, delicate reconstruction of intrahepatic conduits, and meticulous postoperative management can improve patient survival and reduce the incidence of complications.
